Clinical Trial Update: Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how HIV infection status influences the cellular pharmacology of antiretrovirals tenofovir disoproxil fumarate and emtricitabine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED